The data and potential of LUM-201 (ibutamoren)

[madman]

To view this content we will need your consent to set third party cookies.
For more detailed information, see our cookies page.

Accept third party cookies

Andrew Dauber, M.D., Chief of Endocrinology, Children's National Medical Center, Washington, D.C. discusses the data and potential of LUM-201 for children living with moderate pediatric growth hormone deficiency

 

[madman]

LUM-201 (ibutamoren) - The OraGrowtH212 trial

The OraGrowtH212 trial is a global study involving 80 patients in four arms, testing three different doses of a new drug compared to the standard dose of growth hormone. The study aims to measure catchup growth over an extended period, with promising interim results indicating comparable growth...

www.excelmale.com